Treatment of ankylostomiasis with levamisole.
The authors communicate their experience in the treatment of ankylostomiase with levamisole; with a dose of 2.5 mg/kg body weight they achieved a positive result in two-thirds of the cases in a series of 119 without any toxic side effects.
D000724:Ancylostomiasis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male
D007978:Levamisole